Podcast

Type 1 Diabetes and Running Marathons

Scott Hanselman of ComputerZen.com discusees running marathons as a patient with type 1 diabetes.

Scott Hanselman of ComputerZen.com discusees running marathons as a patient with type 1 diabetes with fellow diabetic Gary Schmidt.

Click here to access this third-party resource.

Related Videos
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Related Content
Dhruv Kazi, MD | Credit: PCSK9 Forum
November 18th 2024

More than 50% of US Adults Considered Eligible for Semaglutide with Current Labeling

Patrick Campbell
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
US FDA logo in black over a white background. | Credit: US Food and Drug Administration
November 2nd 2024

FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

Patrick Campbell
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity
October 30th 2024

10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity

Chelsie Derman
Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center
October 21st 2024

Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.